Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-07-15

FDA Approved: TERIFLUNOMIDE — Supplemental Application (Teva Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Teriflunomide from Teva Pharmaceuticals, Inc. This action indicates FDA approval of a supplemental submission re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Teriflunomide (teriflunomide)

Snippet

SUPPL AP for TERIFLUNOMIDE (TERIFLUNOMIDE)